MedPath

浙江经纬药业有限公司

Ownership
-
Established
1998-11-30
Employees
-
Market Cap
-
Website
http://www.zjjwpharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

11

NMPA:11

Drug Approvals

Compound Mentholatum Ointment

Product Name
复方薄荷脑软膏
Approval Number
国药准字H20073760
Approval Date
Jul 12, 2022
NMPA

Ftibamzone

Product Name
酞丁安
Approval Number
国药准字H33021477
Approval Date
Jan 18, 2021
NMPA

复方猴头胶囊

Approval Number
国药准字Z20020026
Approval Date
May 8, 2020
NMPA

Pediatric Paracetamol,Atificial Cow-bezoar and Chlorphenamine Maleate Granules

Product Name
小儿氨酚黄那敏颗粒
Approval Number
国药准字H33022026
Approval Date
Apr 30, 2020
NMPA

清肝颗粒

Approval Number
国药准字Z20026167
Approval Date
Apr 30, 2020
NMPA

复方猴头颗粒

Approval Number
国药准字Z33020865
Approval Date
Apr 29, 2020
NMPA

Ftibamzone Cream

Product Name
酞丁安乳膏
Approval Number
国药准字H33021478
Approval Date
Apr 29, 2020
NMPA

Naproxen Dispersible Tablets

Product Name
步生
Approval Number
国药准字H20010486
Approval Date
Apr 29, 2020
NMPA

Compound Miconazole Nitrate Cream

Product Name
咪康唑氯倍他索乳膏
Approval Number
国药准字H33022132
Approval Date
Apr 29, 2020
NMPA

Xylitol Granules

Product Name
木糖醇颗粒
Approval Number
国药准字H33021847
Approval Date
Apr 29, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.